All articles by Staff Writer
Staff Writer
Trisol announces successful implants of its Transcatheter Tricuspid Valve in the US
Two implants were successfully conducted as part of the FDA approved Early Feasibility Study in the United States
IVI and the Madagascar Institute for Vaccine Research launch typhoid conjugate vaccine campaign for infants and children
The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and the Madagascar Institute for Vaccine Research (MIVR) at the University of Antanararivo held a ceremony today to launch a mass vaccination campaign against typhoid in the Arivonimamo and Antananarivo-Atsimondrano districts of Madagascar.
TB Alliance Announces Partnership with Remington Pharmaceuticals to Commercialize New Therapy for Drug-Resistant Forms of TB in Pakistan
Non-profit drug developer partners with leading manufacturer of medicine in Pakistan
MediCardia integrates wearable ECG for atrial fibrillation care
This integration claims to streamline AF care through remote monitoring and virtual health services.
TNAA acquires Stogo to address healthcare staffing shortage
Stogo, set up by Acute Care Hospital executives, helps resolve staff shortfall and scheduling hurdles faced by health systems.
Polpharma Biologics Announces FDA Approval of Tyruko® – First And Only Approved Biosimilar to Tysabri®* for Relapsing Forms of Multiple Sclerosis
Polpharma Biologics, an international biotech company dedicated to the development and manufacture of biosimilars, announced today that the U.S. Food and Drug Administration (FDA) is the first regulatory body worldwide to approve the use of Tyruko® (natalizumab-sztn) – a new biosimilar for the treatment of relapsing forms of multiple sclerosis (MS). Approval of Tyruko® by the European Medicines Agency is also expected imminently.
Genetic Signatures Announces Strategic Partnership with Integrated Gulf Biosystems for Expanded Market Reach in the Middle East
Genetic Signatures, a leading innovator in molecular diagnostics, is pleased to announce a new channel partner in the Middle East, Integrated Gulf Biosystems (IGB). With IGB’s headquarters in Dubai, the exclusive agreement allows Genetic Signatures to tap into the promising market of United Arab Emirates, Kingdom of Saudi Arabia, Bahrain and Qatar. This partnership is a significant step forward in Genetic Signatures’ mission to expand its market presence in the Middle East, providing clinical diagnostic laboratories access to its patented 3base® technology, and syndromic testing solutions for infectious diseases.
Pandemic prevention: progress in research infrastructure
Interview with Prof. Claudia Traidl-Hoffmann, Director of the Institute of Environmental Medicine, Helmholtz Munich, and Professor of Environmental Medicine at the University of Augsburg
Roche launches a new addition to the cobas® connection modules, the CCM Vertical, helping to improve laboratory efficiency
Roche announced today that it has a new addition to the cobas® connection modules (CCM), the CCM Vertical, allowing transportation of samples on overhead conveyors.* This solution allows for CCM conveyors to cross walkways, connecting different work areas and keeps (emergency) exits accessible. Samples can also be transported up or down to different levels.
Wellcome and the Gates Foundation to Fund Late-Stage Development of a Tuberculosis Vaccine Candidate That Could Be the First in 100 Years If Proven Effective
TB is one of the world’s deadliest diseases, killing about 4,300 people per day, mostly those living in poverty